Mavoglurant in Alcohol Drinking

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 7, 2018

Primary Completion Date

July 13, 2023

Study Completion Date

July 13, 2023

Conditions

Alcohol Drinking

Interventions

DRUG

Mavoglurant

200 mg Mavoglurant

DRUG

Placebo

Trial Locations (1)

CMHC, Substance Abuse Center, New Haven

All Listed Sponsors

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER

NCT03327792 - Mavoglurant in Alcohol Drinking | Biotech Hunter | Biotech Hunter